Yusuf Deeni

Dr. Yusuf Deeni


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in The Lancet
Verified
Journal Article
Closed access
GSGillian Smith
Gillian Smith
CWC Roland Wolf
C Roland Wolf
YDYusuf Deeni
Yusuf Deeni
RDRobert S Dawe
Robert S Dawe
AEAlan T Evans
Alan T Evans
SISally Ibbotson
Sally Ibbotson


1 January 1991 in International Journal of Pharmacognosy
Verified
Journal Article
Closed access
PDF file
HHH. S. N. Hussain
H. S. N. Hussain
YDYusuf Deeni
Yusuf Deeni
Kano is a region of Nigeria located between latitude 10° 30′N and 13° 03′N. It has the Sudan savannah type of climate and vegetation that gradually gives way to semi-arid conditions northward. It is a part of the Hausaland where ethnomedicine is recognized and practiced. From our previous work (Hussain and Karatela, 1989) and additional information from herbalists, plants used to treat microbial diseases or disorders were selected. In addition Tapinanthus species growing on hosts that have been implicated in antibiosis (Lewis and Elvin-Lewis, 1979; Oliver, 1959 and Sofowora, 1982) were also included. Thus we thought it might be appropriate and useful, as with the flora of other lands (Al-Shamma and Mitscher, 1979; Chhabra et al, 1981 and Van Puyelde et al., 1981) to screen these plants to ascertain their antimicrobial efficacy and potential economic value. In this paper, alcoholic extracts of some plants have been tested for an in vitro antimicrobial activity against thirteen indicator organisms and the presence of alkaloids.

1 October 1991 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YDYusuf Deeni
Yusuf Deeni
HHH.S.N. Hussain
H.S.N. Hussain

1 May 2015 in Journal of Biotechnology
Verified
Journal Article
Open access
HKHilal S. Khalil
Hilal S. Khalil
AGAlexey Goltsov
Alexey Goltsov
Simon LangdonSimon Langdon
Simon Langdon
DHDavid Harrison
David Harrison
JBJames Bown
James Bown
YDYusuf Deeni
Yusuf Deeni
Cells are constantly exposed to Reactive Oxygen Species (ROS) produced both endogenously to meet physiological requirements and from exogenous sources. While endogenous ROS are considered as important signalling molecules, high uncontrollable ROS are detrimental. It is unclear how cells can achieve a balance between maintaining physiological redox homeostasis and robustly activate the antioxidant system to remove exogenous ROS. We have utilised a Systems Biology approach to understand how this robust adaptive system fulfils homeostatic requirements of maintaining steady-state ROS and growth rate, while undergoing rapid readjustment under challenged conditions. Using a panel of human ovarian and normal cell lines, we experimentally quantified and established interrelationships between key elements of ROS homeostasis. The basal levels of NRF2 and KEAP1 were cell line specific and maintained in tight correlation with their growth rates and ROS. Furthermore, perturbation of this balance triggered cell specific kinetics of NRF2 nuclear-cytoplasmic relocalisation and sequestration of exogenous ROS. Our experimental data were employed to parameterise a mathematical model of the NRF2 pathway that elucidated key response mechanisms of redox regulation and showed that the dynamics of NRF2-H2O2 regulation defines a relationship between half-life, total and nuclear NRF2 level and endogenous H2O2 that is cell line specific.

1 October 2012 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
JBJames Bown
James Bown
PAPaul S. Andrews
Paul S. Andrews
YDYusuf Deeni
Yusuf Deeni
AGAlexey Goltsov
Alexey Goltsov
MIMichael Idowu
Michael Idowu
SSSusan Stepney
Susan Stepney
Abstract: Computer simulation can be used to inform in vivo and in vitro experimentation, enabling rapid, low-cost hypothesis generation and directing experimental design in order to test those hypotheses. In this way, in silico models become a scientific instrument for investigation, and so should be developed to high standards, be carefully calibrated and their findings presented in such that they may be reproduced. Here, we outline a framework that supports developing simulations as scientific instruments, and we select cancer systems biology as an exemplar domain, with a particular focus on cellular signalling models. We consider the challenges of lack of data, incomplete knowledge and modelling in the context of a rapidly changing knowledge base. Our framework comprises a process to clearly separate scientific and engineering concerns in model and simulation development, and an argumentation approach to documenting models for rigorous way of recording assumptions and knowledge gaps. We propose interactive, dynamic visualisation tools to enable the biological community to interact with cellular signalling models directly for experimental design. There is a mismatch in scale between these cellular models and tissue structures that are affected by tumours, and bridging this gap requires substantial computational resource. We present concurrent programming as a technology to link scales without losing important details through model simplification. We discuss the value of combining this technology, interactive visualisation, argumentation and model separation to support development of multi-scale models that represent biologically plausible cells arranged in biologically plausible structures that model cell behaviour, interactions and response to therapeutic interventions.